Crossmark

Increased CD4+ T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients

Crossref DOI link: https://doi.org/10.1186/s13148-018-0536-6

Published Online: 2018-08-03

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ahlén Bergman, Emma http://orcid.org/0000-0002-6957-7129
Hartana, Ciputra Adijaya

Johansson, Markus

Linton, Ludvig B.

Berglund, Sofia

Hyllienmark, Martin

Lundgren, Christian

Holmström, Benny

Palmqvist, Karin

Hansson, Johan

Alamdari, Farhood

Huge, Ylva

Aljabery, Firas

Riklund, Katrine

Winerdal, Malin E.

Krantz, David

Zirakzadeh, A. Ali

Marits, Per

Sjöholm, Louise K.

Sherif, Amir

Winqvist, Ola
Funding

Funding for this research was provided by:

Cancerfonden

Knut och Alice Wallenbergs Stiftelse

Vetenskapsrådet

Regionala forskningsrådet i Uppsala-Örebroregionen (RFR in Uppsala-Örebro)

Vetenskapsrådet funding for clinical research in medicine (ALF) in Västerbotten

Västerbotten Läns Landsting

Cancer Research Foundation in Northern Sweden (SE)

Stiftelsen Emil Anderssons fond för Medicinsk forskning
License Information

Text and Data Mining valid from 2018-08-03
More Information

Article History

Received: 1 March 2018

Accepted: 24 July 2018

First Online: 3 August 2018

Ethics approval and consent to participate

: The study was approved by the local ethical committee (original dnr: 2007/71-31 with latest amendment 2017/190-32, both EPN-Stockholm).

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.